105 related articles for article (PubMed ID: 22643182)
1. Back to the embryonic stage: Nodal as a biomarker for breast cancer progression.
Bar-Eli M
Breast Cancer Res; 2012 May; 14(3):105. PubMed ID: 22643182
[TBL] [Abstract][Full Text] [Related]
2. Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.
Strizzi L; Hardy KM; Margaryan NV; Hillman DW; Seftor EA; Chen B; Geiger XJ; Thompson EA; Lingle WL; Andorfer CA; Perez EA; Hendrix MJ
Breast Cancer Res; 2012 May; 14(3):R75. PubMed ID: 22577960
[TBL] [Abstract][Full Text] [Related]
3. Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment.
Bodenstine TM; Chandler GS; Reed DW; Margaryan NV; Gilgur A; Atkinson J; Ahmed N; Hyser M; Seftor EA; Strizzi L; Hendrix MJ
Cell Cycle; 2016 May; 15(9):1295-302. PubMed ID: 27007464
[TBL] [Abstract][Full Text] [Related]
4. Embryonic morphogen nodal promotes breast cancer growth and progression.
Quail DF; Zhang G; Walsh LA; Siegers GM; Dieters-Castator DZ; Findlay SD; Broughton H; Putman DM; Hess DA; Postovit LM
PLoS One; 2012; 7(11):e48237. PubMed ID: 23144858
[TBL] [Abstract][Full Text] [Related]
5. Increasing Embryonic Morphogen Nodal Expression Suggests Malignant Transformation in Colorectal Lesions and as a Potential Marker for CMS4 Subtype of Colorectal Cancer.
Wang X; Liu S; Cao H; Li X; Rong Y; Liu G; Du H; Shen H
Pathol Oncol Res; 2021; 27():587029. PubMed ID: 34257534
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.
Lawrence MG; Margaryan NV; Loessner D; Collins A; Kerr KM; Turner M; Seftor EA; Stephens CR; Lai J; ; Postovit LM; Clements JA; Hendrix MJ
Prostate; 2011 Aug; 71(11):1198-209. PubMed ID: 21656830
[TBL] [Abstract][Full Text] [Related]
7. Human Cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes.
Aykul S; Ni W; Mutatu W; Martinez-Hackert E
PLoS One; 2015; 10(1):e0114954. PubMed ID: 25603319
[TBL] [Abstract][Full Text] [Related]
8. Low oxygen levels induce the expression of the embryonic morphogen Nodal.
Quail DF; Taylor MJ; Walsh LA; Dieters-Castator D; Das P; Jewer M; Zhang G; Postovit LM
Mol Biol Cell; 2011 Dec; 22(24):4809-21. PubMed ID: 22031289
[TBL] [Abstract][Full Text] [Related]
9. [Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].
Liu RB; Zhou XH; Wang JN; Liang HZ; Li XX; Wu ZH; Ye JL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3397-400. PubMed ID: 19159568
[TBL] [Abstract][Full Text] [Related]
10. Expression of the embryological morphogen Nodal in stage III/IV melanoma.
Hooijkaas AI; Gadiot J; van Boven H; Blank C
Melanoma Res; 2011 Dec; 21(6):491-501. PubMed ID: 22002671
[TBL] [Abstract][Full Text] [Related]
11. L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
Wu JD; Hong CQ; Huang WH; Wei XL; Zhang F; Zhuang YX; Zhang YQ; Zhang GJ
Clin Breast Cancer; 2018 Oct; 18(5):e851-e861. PubMed ID: 29510897
[TBL] [Abstract][Full Text] [Related]
12. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.
Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A
Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966
[TBL] [Abstract][Full Text] [Related]
13. Impact of Neoadjuvant Chemotherapy on Nodal Disease and Nodal Surgery by Tumor Subtype.
Al-Hilli Z; Hoskin TL; Day CN; Habermann EB; Boughey JC
Ann Surg Oncol; 2018 Feb; 25(2):482-493. PubMed ID: 29181679
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.
Aitken SJ; Thomas JS; Langdon SP; Harrison DJ; Faratian D
Ann Oncol; 2010 Jun; 21(6):1254-1261. PubMed ID: 19858088
[TBL] [Abstract][Full Text] [Related]
15. Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
Alqaisi A; Chen L; Romond E; Chambers M; Stevens M; Pasley G; Awasthi M; Massarweh S
Breast Cancer Res Treat; 2014 Nov; 148(2):437-44. PubMed ID: 25257728
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
17. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
19. Nodal signalling in embryogenesis and tumourigenesis.
Quail DF; Siegers GM; Jewer M; Postovit LM
Int J Biochem Cell Biol; 2013 Apr; 45(4):885-98. PubMed ID: 23291354
[TBL] [Abstract][Full Text] [Related]
20. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
Pilewskie M; Zabor EC; Mamtani A; Barrio AV; Stempel M; Morrow M
Ann Surg Oncol; 2017 Nov; 24(12):3527-3533. PubMed ID: 28762114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
